Skip to content
Elite Peptides

[ Healing & recovery research ]

GLOW70 in Australia: a three-peptide healing-blend research guide

What GLOW70 is — a co-lyophilised research blend of BPC-157, GHK-Cu and TB-500 — what each component brings, why they are combined in one vial, and how the per-component content is HPLC-verified. A laboratory research reference for Australian researchers.

7 min read · Updated 22 July 2026

GLOW70 co-lyophilised research blend vial — BPC-157, GHK-Cu and TB-500, independently HPLC-content-tested, COA on file

[ Research use only · Not for human consumption ]

GLOW70 in Australia. GLOW70 is a multi-component research blend supplied co-lyophilised in a single vial — BPC-157, GHK-Cu and TB-500 — for researchers working across the soft-tissue and copper-peptide research literature in one reconstitution. This guide is a research-reference summary for Australian researchers; it makes no medical, cosmetic, or human-use claim.

Three research strands in one vial

GLOW70 is a formulation rather than a single chemical entity, so it has no single CAS number or molecular weight — each of its three peptides carries its own identity. BPC-157 (a synthetic pentadecapeptide) and TB-500 (the research-peptide name for thymosin β-4, the 43-residue G-actin-sequestering peptide) are the two soft-tissue-repair peptides; GHK-Cu (the copper(II)-complexed tripeptide) is the copper-peptide component. The blend co-presents two soft-tissue-repair strands with a copper-peptide in one vial (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg).

The research behind the components

BPC-157 and thymosin β-4 are both referenced across the soft-tissue-repair, wound-healing and angiogenesis research strand — reviewed for BPC-157 by Seiwerth and colleagues (Frontiers in Pharmacology, 2021) and for thymosin β-4 by Goldstein and colleagues (Expert Opinion on Biological Therapy, 2012). GHK-Cu sits in the copper-peptide / dermal-remodelling research strand, reviewed by Pickart and Margolina (International Journal of Molecular Sciences, 2018). The BPC-157, TB-500 and GHK-Cu guides cover each component in depth.

Why the blend runs blue — and how it is tested

GHK-Cu is the copper-chelate component and gives the reconstituted solution its characteristic blue tint — expected, and a useful batch-consistency marker. Because each of the three peptides is independently HPLC-content-tested by Janoshik, the blend’s certificate reports the measured content of every component rather than a single combined figure — research-honest, not marketing-shorthand. The certificate is published on the product page and in the lab-reports library.

GLOW70 versus KLOW80, reconstitution and compliance

GLOW70 is the three-peptide healing blend; the related KLOW80 blend adds the melanocortin-derived tripeptide KPV as a fourth component. Reconstitute the co-lyophilised vial with bacteriostatic water — the reconstitution guide covers the per-component concentration math. GLOW70 is not TGA-approved and is not a therapeutic good; Elite AU Peptides makes no medical, cosmetic, or human-use claim, and supplies it strictly for in-vitro and laboratory research use only.

[ Frequently asked ]

Healing & recovery research — questions researchers ask.

What is in the GLOW70 blend?
GLOW70 is a multi-component research blend supplied co-lyophilised in a single vial — BPC-157, GHK-Cu and TB-500 (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg). Each component is independently HPLC-content-tested by Janoshik before the batch is listed. Elite AU Peptides supplies it strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, and not TGA-approved.
What does each component bring to the blend?
BPC-157 (a pentadecapeptide) and TB-500 (thymosin β-4) are the two soft-tissue-repair peptides, referenced across the wound-healing and angiogenesis literature (reviewed for BPC-157 by Seiwerth and colleagues, Frontiers in Pharmacology, 2021, and for thymosin β-4 by Goldstein and colleagues, Expert Opinion on Biological Therapy, 2012). GHK-Cu is the copper-peptide component, reviewed by Pickart and Margolina (International Journal of Molecular Sciences, 2018). The blend co-presents three distinct research strands in one vial.
Why does reconstituted GLOW70 turn blue?
The GHK-Cu component is a copper(II) complex, and its coordination chemistry gives the reconstituted solution a characteristic blue tint — expected, and a useful batch-consistency marker. The reconstitution guide covers the concentration math for multi-component vials.
How is a multi-component blend tested?
Every batch is independently HPLC-content-tested by Janoshik. Because it is a multi-peptide vial, the certificate reports the measured content of each component rather than a single combined purity figure — research-honest, not marketing-shorthand. Nothing is listed without certificates on file.
How is GLOW70 different from KLOW80?
GLOW70 is the three-peptide healing blend (BPC-157, GHK-Cu, TB-500). KLOW80 extends it with a fourth component — the melanocortin-derived tripeptide KPV. See the KLOW80 guide for the four-peptide blend.
How is GLOW70 reconstituted and shipped?
Reconstitute the co-lyophilised vial with bacteriostatic water; the per-component content on the certificate is the reference for the concentration math. Dispatched AU-domestic, free shipping over $100, same-day dispatch before 12pm AEST. Supplied strictly for laboratory research use only.

Elite AU Peptides supplies research peptides and related compounds for laboratory and in-vitro research use only. Products are not therapeutic goods, are not TGA-approved, and are not for human or animal consumption. Nothing on this site constitutes medical advice or a therapeutic claim. Purchasers must be 18 years or older and are responsible for complying with all applicable laws in their jurisdiction.